Gross-Goupil, M., & Ravaud, A. (2012). Tivozanib: Is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer? Transl Androl Urol.
Styl ChicagoGross-Goupil, Marine, a Alain Ravaud. "Tivozanib: Is Total VEGFR Inhibition the Way to Success in Terms of Tolerability and Efficacy in Advanced Kidney Cancer?" Transl Androl Urol 2012.
Citace podle MLAGross-Goupil, Marine, a Alain Ravaud. "Tivozanib: Is Total VEGFR Inhibition the Way to Success in Terms of Tolerability and Efficacy in Advanced Kidney Cancer?" Transl Androl Urol 2012.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..